Michaelson Jennifer's Form 4 filing
Cullinan Therapeutics, Inc. (CGEM) · filed Dec 16, 2025
- Accession no.
- 0001193125-25-321122
- Filed
- Dec 16, 2025
- Trade date
- Dec 12-15, 2025
- Filing delay
- 4 days
- Rule 10b5-1 plan
- Checked
This filing lists 2 non-derivative transactions and 0 derivative transactions. Open-market sales total $38.4K. It was filed 4 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Michaelson JenniferCIK 0001838061 | Officer (Chief Scientific Officer) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Dec 12, 2025 | Common Stock | SSaleDisposed | −2,148 | $12.38 | −$26,592.24 | 137,873 | Direct | |
| Dec 15, 2025 | Common Stock | SSaleDisposed | −995 | $11.90 | −$11,840.5 | 136,878 | Direct |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.